EP 1163029 A2 20011219 - NITRATE ESTERS AND THEIR USE FOR INDUCING NEUROPROTECTION AND COGNITION ENHANCEMENT
Title (en)
NITRATE ESTERS AND THEIR USE FOR INDUCING NEUROPROTECTION AND COGNITION ENHANCEMENT
Title (de)
NITRATEN ESTER UND DEREN VERWENDUNG ZUR NEUROPROTEKTION UND WAHRNEHMUNGSSTEIGERUNG
Title (fr)
ESTERS DE NITRATE ET LEUR UTILISATION DANS LE TRAITEMENT D'ETATS NEUROLOGIQUES
Publication
Application
Priority
- CA 0000280 W 20000315
- US 26737999 A 19990315
Abstract (en)
[origin: US6916835B2] Compounds and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic compound comprising a nitrate ester, or a pharmaceutically acceptable salt or ester thereof.
IPC 1-7
IPC 8 full level
A61K 31/21 (2006.01); A61K 31/255 (2006.01); A61K 31/26 (2006.01); A61K 31/275 (2006.01); A61K 31/34 (2006.01); A61K 31/341 (2006.01); A61K 31/381 (2006.01); A61K 31/385 (2006.01); A61K 31/39 (2006.01); A61K 31/426 (2006.01); A61K 31/506 (2006.01); A61K 31/513 (2006.01); A61K 31/575 (2006.01); A61K 31/662 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 39/06 (2006.01); A61P 43/00 (2006.01); C07C 203/04 (2006.01); C07C 255/14 (2006.01); C07C 317/18 (2006.01); C07C 323/12 (2006.01); C07C 327/28 (2006.01); C07C 331/10 (2006.01); C07C 381/02 (2006.01); C07D 277/24 (2006.01); C07D 307/33 (2006.01); C07D 327/04 (2006.01); C07D 333/48 (2006.01); C07D 339/08 (2006.01); C07D 411/04 (2006.01); C07F 9/09 (2006.01); C07F 9/40 (2006.01); C07J 9/00 (2006.01); C07J 41/00 (2006.01)
CPC (source: EP US)
A61K 31/21 (2013.01 - EP US); A61K 31/255 (2013.01 - EP US); A61K 31/26 (2013.01 - EP US); A61K 31/275 (2013.01 - EP US); A61K 31/341 (2013.01 - EP US); A61K 31/381 (2013.01 - EP US); A61K 31/39 (2013.01 - EP US); A61K 31/426 (2013.01 - EP US); A61K 31/506 (2013.01 - EP US); A61K 31/575 (2013.01 - EP US); A61K 31/662 (2013.01 - EP US); A61K 31/7068 (2013.01 - EP US); A61P 25/00 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 39/06 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 203/04 (2013.01 - EP US); C07C 255/14 (2013.01 - EP US); C07C 317/18 (2013.01 - EP US); C07C 323/12 (2013.01 - EP US); C07C 327/28 (2013.01 - EP US); C07C 331/10 (2013.01 - EP US); C07C 381/02 (2013.01 - EP US); C07D 277/24 (2013.01 - EP US); C07D 307/33 (2013.01 - EP US); C07D 327/04 (2013.01 - EP US); C07D 333/48 (2013.01 - EP US); C07D 339/08 (2013.01 - EP US); C07D 411/04 (2013.01 - EP US); C07F 9/091 (2013.01 - EP US); C07F 9/4006 (2013.01 - EP US); C07J 41/0061 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0054756 A2 20000921; WO 0054756 A3 20010125; AT E546195 T1 20120315; AU 3267300 A 20001004; AU 783036 B2 20050915; CA 2364493 A1 20000921; CA 2364493 C 20100831; EP 1163029 A2 20011219; EP 1163029 B1 20120222; IL 145367 A0 20020630; JP 2002539152 A 20021119; MX PA01009246 A 20040326; US 2002016311 A1 20020207; US 2002147234 A1 20021010; US 2002177622 A1 20021128; US 6310052 B1 20011030; US 6365579 B2 20020402; US 6677374 B2 20040113; US 6916835 B2 20050712
DOCDB simple family (application)
CA 0000280 W 20000315; AT 00910456 T 20000315; AU 3267300 A 20000315; CA 2364493 A 20000315; EP 00910456 A 20000315; IL 14536700 A 20000315; JP 2000604832 A 20000315; MX PA01009246 A 20000315; US 10851302 A 20020329; US 14780802 A 20020520; US 26737999 A 19990315; US 85159101 A 20010510